RNXT

RenovoRx, Inc.

Healthcare · Biotechnology

$55.33 sample

+0.76 (+1.39%) 1D

Market cap

$321.5B

Price as of

2026-10-04

Latest filing

8-K · 2026-08-24

Alerts

8

Price$55.33 +21.90% 3M daily closessample

55.3345.07

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider buy: Chief Financial Officer
Sep 23INSInsider sell: Chief Financial Officer
Sep 17INSInsider sell: 10% owner
Sep 08INSInsider sell: 10% owner
Sep 03INSInsider buy: Director
Aug 27INSInsider sell: Chief Financial Officer
Aug 24SECForm 144 filed
Aug 13SEC10-Q filed

Sign up to see the real RNXT record →

Company facts

SEC EDGAR registration

Name: RenovoRx, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -48sample, -100 to +100
Reporting currency: USD

Who is positioning in RNXT

sample

Insiders: 10 insider transactions over 90 days, net selling, $700.9M
Congress: 2 members traded over 90 days
Institutions · 13F: 7 funds hold $2.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$18.6B +20.2% y/y

Q4 2024Q3 2026

Inventory$10.8B +9.2% y/y

Q4 2024Q3 2026

Accounts receivable$8.2B +8.7% y/y

Q4 2024Q3 2026

Total debt$22.9B +15.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $272.6B -12.7% 3M
Sample peer B: $128.4B +3.9% 3M
Sample peer C: $37.8B -5.3% 3M
Sample peer D: $61.6B -7.1% 3M
Sample peer E: $303.0B +16.2% 3M